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1. Introduction  
Human immunodeficiency virus type I (HIV-1) is widely accepted as the cause of AIDS. It is 
also believed that HIV-1 itself is sufficient to cause immunodeficiency and to destroy 
parenchyma cells inducing widespread organ failure. Despite the unquestionable success in 
diagnosis and therapy of this disease, there are many unanswered questions. The substantial  
argument of this predication is the fact that it is still not possible to stop the worldwide 
pervasion of AIDS, especially in Africa and Asia. Without giving answers to all these 
questions a more successful treatment of patients cannot be expected. The fight against this 
disease is challenging and should be realized in a more complex manner, overcoming all the 
taboos and dogmas surrounding the disease. It is necessary to deliberate other potential 
factors, not only HIV, which may take part in this disease. 
Plasma HIV RNA is dramatically reduced in HIV/AIDS patients treated with highly active 
antiretroviral therapy (HAART), but residual viral replication is detected after suppression of 
plasma viraemia (Chun et al., 2000; Cusisni et al., 2004). It has also been expressly proven that 
various forms of HIV reservoirs persist in practically all patients receiving HAART (Finzi et al., 
1997; Siliciano et al., 2003). The range of viral reservoirs in the human body is probably very 
much wider, as claimed in recent studies. Reservoirs were detected in macrophages and other 
cells of the blood system, in which even very effective HAART was not able to eliminate the 
virus. HIV persists in peripheral blood mononuclear cells despite sustained, undetectable 
plasma viraemia resulting from long-term antiretroviral therapy (Veazey et al., 1998; Brenchley 
et al., 2004). The source of persistent HIV in these infected persons remains however unclear.  
Over the last period of time AIDS research has been focused on the gut and other mucosal 
tissue, and not blood, as the major site of HIV infection and CD4+ T cells loss (Veazey et al., 
2005). Mattapallil and Li both showed that the major focus of destruction of memory CD4+ 
T cells by simian immunodeficiency virus (SIV) is in mucosal cells, where most T cells 
expressing CD4 and CCR5 with a “memory” phenotype reside (Mattapallil et al., 2005; Li et 
al., 2005). The loss of CD4+ T cells in the intestine coincided with productive infection of 
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large numbers of mononuclear cells at this site (Veazey et al., 1990). These recent findings 
support the idea that the mucosal and intestine immune system is the major site of viral 
replication, persistence and CD4+ T cells loss in HIV-1 infected persons (Guadalupe et al., 
2006; Dandekar et al., 2007; Ling et al., 2007, 2010;  Lackner et al., 2009; Hatziioannou et al., 
2009). HIV-1 has been also detected in bowel crypt cells and the lamina propria from 
patients with gastrointestinal symptoms (Nelson et al., 1988). The pathogenesis of HIV 
infection is presumably centered on these mucosal viral “target” cells. Since these cells are in 
close vicinity to intestinal bacteria, the idea has been raised that bacteria may also be 
involved in AIDS pathogenesis. 
 This interest in investigating bacteria and mycoplasma was also supported by Montagnier’s 
finding, confirmed by Shyh-Ching Lo, that mycoplasma is a very important “co-factor” 
which accelerates the progression of HIV infection in AIDS patients (Montagnier, 1986; Lo et 
al., 1991). And finally, Cantwell and Broxmeyer pointed out that there is a very close 
relationship between bacteria and cancer, resp. AIDS (Cantwell, 1983, 1993; Broxmeyer & 
Cantwell, 2008). 
2. Molecular biology analysis of bacteria and yeasts of HIV positive patients  
2.1 Dot blot DNA hybridization. 
To verify this idea, bacterial DNA isolated from the gastrointestinal tract and blood DNA of 
51 AIDS patients and 10 healthy subjects were tested for the presence of HIV-1 sequences by 
colony and dot blot hybridization (Zajac et al., 2005,  2006, 2007, 2011). In dot blot 
hybridization, the lymphocyte/bacterial DNA of American and Slovak HIV/AIDS patients 
were in most cases positive (Figure 1). Of 27 patient samples, 23 lymphocyte DNA and 20 
bacterial were positive, with respective 85% and 74%. Yet positivity of all the 41 patients 
tested was approximately the same. The selected patients 23, 33, 44, 78, 30, P1 and P15 are 
localized as follows: patient 23 in line 2 - position 1,2; patient 33 in line 1 – 5,6; patient 44 in 
line 4 – 3,4; patient 78 in line 6 – 1,2; patient 30 in line 7 – 1,2; patient P1 in line 7 –3,4 and 
patient P15 in line 7 – 5,6. The intensity of the hybridization signal was in correlation with 
the origin of the probes used, the signal of human samples was more intensive with the 
applied human probes and vice versa for bacterial probes (data not shown). These findings 
suggest some differences in sequences between the two sources of material. The 
hybridization signals of samples from patients 96, 83, 62 (line 3, position 5, 6; line 4, position 
1, 2; line 2, position 5, 6) were not intensive either in lymphocyte or bacterial DNA. These 
patients were classified as A1 stage of their CDC clinical category with CD4+ around 400/┤l. 
The obtained results are in correlation with the common usage of 68; 69 primers in AIDS 
diagnostics. The hybridization signal was not detected in samples of control subjects, with 
the exception of samples from one subject (line 12, position 5,6). 
Bacteria and yeasts from the respiratory tract (nose, pharyngeal swabs) were isolated from 
39 Cambodian and 28 Kenyan HIV-positive children. The majority of microbes were 
characterized as Staphylococcus aureus, Klebsiella pneumoniae and Candida albicans. In some 
cases, E. coli, Streptococcus pyogenes, Proteus mirabilis and Candida tropicalis were identified. 
Bacteria and yeasts of 16 Cambodian (41%) and 8 Kenyan (31%) children were found to be 
positive in colony and dot-blot DNA hybridization (17). Bacteria and yeasts from the 
respiratory tract of 41% of Cambodian (Figure 2) and 31% of Kenyan HIV-positive children 
bear HIV-like sequences.  
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Fig. 1. Dot blot hybridization. DNA of lymphocyte/bacterial DNA (0.2 ┤g) from 27 HIV 
positive patients are on lines 1-9 and from 9 healthy subjects are on lines 10-12. The PCR 
products  38;39, 68;69 and mixture, synthesized on the template of patient 30’s DNA  were 
used as probes. They are on line 13 in position 3, 4, 5 diluted 1:100.  
The PCR specific for HIV sequences was carried out using HIV-1-specific primers. The 
analysis was performed by colony and dot-blot hybridization using HIV-1-specific primers, 
which represent gag, pol and env genes of the virus. 
2.2 PCR and sequencing   
Subsequently, bacterial DNA of positive isolates was amplified by the PCR using two sets of 
primers. The PCR products of 142 bp (primers 68;69, env gene of HIV-1 ) were detected in all 
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Fig. 2. Dot-blot hybridization of bacterial DNA from Cambodian and Kenyan HIV positive 
children. Lines A-G: samples of 42 patients; lines H-I: samples of 8 healthy subjects; line J: in 
position 6 is DNA of AIDS child and in position 2, 3 are probes diluted 1:100 and 1:50. 
bacterial samples tested. The longest PCR products of 1484 bp determined by primers P10: 
CATTTGGAAAGGACCAGCAAAACTACT (HIV-1 pol gene position 4430); 
E1:TCATATGCTTTAGCATCTGATGCACAA (HIV-1 env gene position 5914) were detected 
in 70% of the patient bacterial DNA: M11, P1, P3, P6, P15, P9, M1, M2, M15, M12, M22 
(Figure 3). 
The PCR products synthesized on the template of bacterial DNA analyzed and on the 
template of patient’s DNA using primers from gag, pol and env genes were sequenced. By 
sequencing  PCR products synthesized on the template of the patients’ bacterial DNA using 
primers 68;69 env HIV-1 gene, 68for: AGCAGCAGGAAGCACTATGG, 69rev: 
CCAGACTGTGAGTTGCAACAG) homology greater than 90% with HIV-1 isolate HXB2 
(HIVHXB2CG) was revealed. Sequences of intestinal bacteria of patients revealed at least 
90% homology with three crucial HIV-1 genes (gag, pol, env). Amplified fragments longer 
than 120 bp were directly sequenced on the ABI 373 DNA Sequencer. 
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Fig. 3. The PCR products of 1484 bp determined by primers P10for ; E1rev synthesized on 
the template of bacterial DNA. Lines 1 - 11: AIDS patients; line 12 – PCR without DNA; line 
13 - negative control; line 14 - pBH10; line 15 – marker ┣DNA×HindIII; line 16 - marker 
ϕX174×HaeIII.  
 
 
Fig. 4. Comparison of the sequences of 142 bp PCR products synthesized on the template of 
patients‘ lymphocyte (h) and bacterial (b) DNA, determined by primers 68; 69, of selected 
patients 23, 33, 44, 78, 30, P1 and P15. Abbreviations: Y - C or T, M - A or C, S – G or C, W - 
A or T.  
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The sequences of 142 bp PCR products synthesized on the template of patients‘ 
lymphocyte (h) and bacterial (b) DNA, determined by primers 68; 69, were remarkably 
similar, with some differences occurring between isolates (Figure 4). These minor 
differences in the isolates strongly suggest that the DNA has a common recent ancestry in 
HIV-1. Important is the finding of rather marked differences between bacterial sequences 
and sequences of pBH10 in all fragments tested. On the basis of these results, the 
possibility of contamination of our samples by pBH10 plasmid DNA is practically 
excluded. 
2.3 Protein analysis of patient’s bacteria and yeasts  
The expression of HIV-1 antigens in bacteria and yeasts of HIV positive patients was 
detected by using specific monoclonal antibodies against HIV-1 antigens p17, p24, p55, gp41 
and gp120 (Abcam, UK). 55 kDa protein was detected using MAbs against HIV-1 p24 
approximately  in 30-35% bacterial extracts of HIV positive Cambodian (Km) and Kenyan 
(Ke) tested patients: 14Km, 31Km, 3’Km, 32’Km, 21Ke, 17’Ke, 14’Ke. (Figure 5). 
Using MAbs against gp41 the protein of 41 kDa was identified in 30-35% of bacterial extracts 
of Cambodian and Kenyan and of American and Slovak patients: P79, PEC, P14, P5, P15, P1. 
(Figure 6). 
 
 
Fig. 5. Western blotting of proteins isolated from bacteria and yeasts of the respiratory tract 
(nose, pharyngeal swabs) of Cambodian (Km) and Kenyan (Ke) HIV positive children. 
Detection was performed using monoclonal antibodies against HIV-1 p24. Line 1: p24 
diluted 1:500; line 2: control bacteria Muta 104-0; lines 3-9 tested samples. 
55 kDa protein was also detected in bacteria and yeasts from bacteria and yeasts of the 
respiratory tract (nose, pharyngeal swabs) of Cambodian (Km) and Kenyan (Ke) HIV 
positive children: 14Km, 17’Ke, 21Ke, 32’Km,  3’Km,  31Km, 14’Ke, using by MAbs against 
HIV1 p17, p55 (Figure 7). 
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Fig. 6. Western blotting of proteins isolated from intestinal bacteria of Slovak and American 
HIV positive patients. For detection monoclonal antibodies against HIV-1 gp41 diluted 1:750 
were used. Line 1: negative control; line 2: serum of AIDS patient; line 3: control HB101; 
lines 4-9 tested patients.  
 
 
Fig. 7. Western blotting of proteins isolated from bacteria and yeasts of the respiratory tract 
(nose, pharyngeal swabs) of Cambodian (Km) and Kenyan (Ke) HIV positive children. 
Detection was performed using monoclonal antibodies against HIV-1 p17, p55 diluted 1:750.  
Line 1: serum of AIDS patient diluted 1:100; line 2: negative control; lines 3-9 tested samples.  
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Using monoclonal antibodies against HIV-1 gp120 (1:750), proteins of 75-80 kDa were 
detected in protein extracts from bacteria and yeasts of the respiratory tract (nose, 
pharyngeal swabs) of Cambodian (Km) and Kenyan (Ke) HIV positive children: 14Km, 
17’Ke, 21Ke, 32’Km,  3’Km,  31Km, 14’Ke (Figure 8).  
 
 
Fig. 8. Western blotting of proteins isolated from bacteria and yeasts of the respiratory tract 
(nose, pharyngeal swabs) of Cambodian (Km) and Kenyan (Ke) HIV positive children. Used 
monoclonal antibodies against HIV-1 gp120 (1:750). lines 1-6 tested samples. Line 7: serum 
of AIDS patient diluted 1:100; line 9: negative control bacteria Muta 104-0. 
In samples of Slovak and American HIV positive patients using MAbs against HIV p17, p55 
proteins of about 30 kDa was found. 
In addition, the protein of molecular weight 55 kDa was detected in Cambodian and 
Kenyan samples by MAbs anti HIV-1 p17 and p55. Its molecular weight is comparable to 
gag-encoded Pr55Gag precursor. By MAbs against HIV p24, protein of 55 kDa was found 
in Cambodian and Kenyan samples. Surprisingly, no proteins were found in bacterial 
extract of 10 American and 24 Slovak AIDS patients by this MAbs. Protein detected by 
Mabs against gp41 was identified in 30-35% of samples from all cohorts of patients. The 
protein of about 85 kDa was detected only in Candida species protein extracts of 
Cambodian and Kenyan HIV positive children by the MAbs against gp120. In Slovak and 
American samples, protein reacting with MAbs anti gp120 was not found. These results 
suggest that there are specific differences between bacterial proteins of Slovak and 
American HIV positive patients on one side and Cambodian and Kenyan on the other. 
These differences suggest a diverse bacterial evolution in various geographical areas. 
Microbes of Slovak and American HIV/AIDS patients were most often identified as 
Klebsiella pneumoniae, Escherichia coli, Proteus mirabilis, Citrobacter freundii and Enterobacter 
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aerogenes. Microbes from respiratory tract of Cambodian and Kenyan HIV/AIDS patients 
were most often identified as Staphylococcus aureus, Klebsiella pneumoniae, Candida albicans, 
Candida tropicalis, Enterobacter aerogenes, but also as Escherichia coli and Proteus mirabilis.  
2.4 Tests for internalization capacity of patient’s bacteria 
The obtained results raise the question, what is the role of intestinal bacteria bearing HIV 
sequences in the AIDS process (Simon & Gorbach, 1984). Analogous to the finding of 
Swidsinski (Swidsinski et al., 1998, 2002) and our previous works (Mego et al., 2005, 2006) that 
bacteria isolated from biopsies of polyps, adenomas, and carcinomas are able to internalize 
epithelial cells, we tested bacteria purified from the intestinal tract of Slovak and American 
HIV/AIDS patients for their capacity to be internalized by cells of HL-60 cell line and normal 
human lymphocytes. In the present study, the specific characteristic was found to be their 
vigorous ability to be internalized by HL-60 cells and human lymphocytes, as confirmed by a 
gentamicin protection assay. In comparison with intramucosal bacteria isolated from patients 
with colorectal cancer, their capacity to be internalized by normal human lymphocytes was 5-
10 times higher and in most cases the cells were lysed. Bacteria 725/5 were classified as 
Enterobacter cloacae and all other clones tested were characterized as Escherichia coli. 
Internalization frequently resulted in partial (bacteria of patients M1, M22) or complete lysis 
(patients K1, M12) of HL-60 cells. Partial (patients P3, M22) and complete lysis (patients P1, K1, 
M1, M12) was detected also after infection of normal human lymphocytes. 
What is the fate of bacteria after internalization? As we demonstrate, about 50-60% of the 
bacteria of tested AIDS patients are competent to lyse HL-60 and lymphocytes of host cells. 
The remaining part of intracellular bacteria survived in the host cells for a further 7-10 days, 
as shown by GPA. After this time the GPA test was negative. It can be assumed that in 
nature some pathogenic bacteria which penetrated into the blood system may infect or lyse 
lymphatic cells.  
 
Patient/bacterial clone Number of bacterial colonies 
HIV positive patients 
P15/7 2264 
P1/4 1340 
P3/3 
725/5 
1680 
1140 
M1/6 481/partial lyses of HL-60 cells 
M22/5 27/partial lyses of HL-60 cells 
M12/5 complete lyses of HL-60 cells 
K1/1 complete lyses of HL-60 cells 
Colon cancer patients 
TuSG/1 
883 S/3 
MZRa/3 
71 
104 
44 
negative controls (healthy subjects) <5 
Table 1. Gentamicin protection assay. The number of colonies represents the number of 
intracellular bacteria in HL-60 cells. Number of cells used for assay: HL-60  5x106 ; bacteria 
1x108 
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Patient/bacterial clone Number of bacterial colonies 
HIV positive patients 
P15/7 
P3/3 
725/5 
M22/5 
P1/4 
K1/1 
M1/6 
M12/5 
1121 
320/partial lysis of human lymphocytes 
1140 
423/partial lyses of human lymphocytes 
complete lyses of human lymphocytes 
complete lyses of human lymphocytes 
complete lyses of human lymphocytes 
complete lyses of human lymphocytes 
Colon cancer patients 
TuSG/1 1 
883 S/3 0 
MZRa/3 4 
negative controls (healthy subjects) <5 
Table 2. Gentamicin protection assay. The number of colonies represents the number of 
intracellular bacteria in normal human lymphocytes. Number of used cells: normal human 
lymphocytes 1,5x107;  bacteria 1x108.  
To analyze the role of bacteria in immunodeficiency, reduction of their amount in the 
intestinal tract of 20 AIDS patients was  performed by oral administration of probiotic 
bacteria Escherichia coli strain Nissle 1917. After three months of probiotics treatment the 
viral load decreased or remained on the detection limit (<400 c/ml) in 55.5% of the patients 
tested. According to these findings, it is assumed that not only one biological component 
plays the most important role in the AIDS process, but that there are two – HIV and the 
bacterial host. These bacteria bearing rich extrachromosomal genetic information are able to 
penetrate from the GIT into the human body and attack strongly the human immune 
system. 
3. Etiology and possible evolution of disease 
The fundamental, still unanswered question is the origin of  HIV (Gallo et al., 1985; 
Baltimore, 1985; Duesberg, 1987; Temin, 1988, 1989; Varmus, 1989; Sharp et al., 2001; Zhu et 
al., 1998; Apetrei & Marx, 2005). Is HIV a unique relative of other retroviruses? When 
looking at retroviruses, the rule applies that practically every species in the animal kingdom 
has its own retrovirus – mouse, rat, chicken, goat, sheep, cow, horse, monkey, chimpanzee, 
etc. Some of them are very contiguous, due to their phylogenetic relationship - mouse and 
rat, monkey and chimpanzee. Similarly, retroviruses of monkeys, chimpanzee and humans 
are evolutionarily collateral. Yet there is no substantial evidence about transmission of 
retroviruses between different species in nature. On the basis of these facts and our achieved 
results, it is possible to conclude - all retroviruses have been an integral part of a particular 
host organism since the beginning of their existence as species and they are passed on from 
generation to generation. The hosts – including humans - inherited them from their 
ancestors. In accordance with this idea, it is assumed that transfer of the HIV from apes to 
humans in Africa, as a consequence of their accidental contacts, is not the cause of AIDS 
pandemics.  
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But there is a very serious objection – if HIV were in our bacteria from our beginning, why 
did they emerge only about 25-35 years ago? Were they hidden without any implication all 
the time, for many thousands of years, in our bodies? To answer this question, we should go 
back into the ancient history of humankind. In the past, major epidemics frequently 
occurred when there were new patterns of communication and transportation between 
separately populated areas and/or new patterns of settlement. The first recorded great 
plague occurred in Athens during the Peloponnesian war in 430 BC. In the middle of the 
sixth century AD (542), there was a great outbreak of bubonic plague (Justinianus) in the 
Mediterranean countries, where 40 to 50% of the population died. The biggest cataclysm of 
bubonic plague epidemic started in 1346 in Europe and the population was finally 
decimated by 50 to 60%. Plague subsequently spread to Asia and at least 60 million people 
died just only in China alone. This plague continued up to the seventeenth and partially to 
the eighteenth century. In the sixteenth century, after Europeans reached America, new 
devastating epidemics started among the native peoples resulting in a 90% population loss 
among American Indians within 120 years.  
Who were in particular the victims of these plagues? Mostly people who were 
malnourished, sick, with a debilitated immune system. As discussed above, bacteria 
carrying the rich extra-chromosomal genetic information, as plasmids, phages, 
transposomes, viruses and virus-like particles (HIV included), are mostly pathogenic for the 
host organism and continually attack the immune system after penetration. This attack 
depends on the amount of the microbes which penetrate into the blood. Thus the immune 
system of people with low amounts of these bacteria was stronger and their carriers had a 
chance to overwhelm any plague. One of the most important results of the set of plagues 
that occurred in the history of humankind, mainly in Europe, North Africa, North America 
and partially in Asia, was natural selection, resulting in sanitation of the human population. 
Hand in hand in this tremendous evolution process was the selection of people with a low 
level of bacteria carrying pathogenic, mainly extra-chromosomal genetic information, able to 
penetrate into the human body and attack the immune system. The outcome of this complex 
evolutional proceeding, which finished towards the end of the nineteenth century, was a 
great reduction of pathogenic bacteria in the human population and eventually the 
establishment of a balance between non-pathogenic and pathogenic (“good” and “bad”) 
microbes in the microflora of surviving individuals. The effect of this process was limitation 
of bacteria bearing HIV sequences and the selection of people carrying CCR-5 receptor 
deficiency on white blood cells.  
A consequence of many plagues in the history of mankind was the establishment of a 
balance between prokaryotic and eukaryotic kingdoms in our body, which led to a positive 
selection of people with a low amount of viral and retroviral genetic information in their 
intestinal bacteria. This tremendous process, whose victims were many millions of humans, 
was very intensive particularly in Europe. The stability, acquired over many centuries, 
between eukaryotic and prokaryotic kingdoms was interrupted in the middle of the 
twentieth century due to the use of antibiotics, narcotic drugs and changes in life style 
(homo and anal sex). 
 It is generally accepted that due to ATB practically all primary bacterial pathogens were 
liquidated throughout two-three decades. The success of antibiotics in elimination of many 
diseases induced by microbes was such expressive that in the mid-1950s US Surgeon 
General Steward effusively proclaimed that the era of bacterial diseases finished. This trend 
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of ATB glorification was spread very quickly from USA to Europe and microbiology got to 
the scientific periphery. In 1969, only a few people heard the voice of the English scientist 
J. A. Reaburn who said that in the future years it would be shown that antibiotics could 
bring us unforeseen vicious tricks. 
In this way resistant, potentially pathogenic microbes, bearing rich extra-chromosomal 
genetic information as plasmids, phages, transposomes, virus-like particles (VLP) or viruses 
(including HIV), went from minority to majority and attacked the human immune system. 
Microbes employed their ability to change their shape – cell wall deficient (CWD) to survive 
in these hard conditions or were internalized into host cells (Swidsinski et al., 1998, 2002; 
Martin et al., 2004; Beachey, 1981; Benjamin et al., Cohen & Laux, 1995). Some of these 
microbes are able to overcome insurmountable barriers existing between microbial DNA 
and DNA of more highly organized beings. The result of this process are health troubles and 
one of them, induced by HIV bacteria with strong affinity to T lymphocytes, is 
immunodeficiency.  
This proceeding started between Afro-American drug users because they had not been 
going through plague selection and sanitation, as had other American inhabitants. Disease 
spread mainly in big American cities as Los Angeles, San Fransisco, New York, Chicago, 
and others. Microbes which might be harmless in a healthy body became deadly in 
conjunction with drugs. This hypothesis was put forward in an editorial of the New 
England Journal of Medicine by David Durack: Some new factors may have distorted the 
host-parasite relation. So-called “recreational” drugs are one possibility. They were widely 
used in the large cities where the most of these cases have occurred, and the only patients in 
the series reported with this issue who were not homosexual were drug users. Perhaps one 
of these recreational drugs is an immunosuppressive agent (Durack and Phil, 1981). The 
leading candidates were nitrites, which were commonly inhaled in the years 1960 to 1977 to 
intensify orgasm. Butyl nitrite very probably plays an important role in induction of 
Kaposi‘s sarcoma in AIDS (Mirwish & Hawerkos, 1987). Mice exposed to isobutyl nitrite 
showed dose-related immune system damage and became highly susceptible to disease and 
death caused by mycobacterial infection (Neefe et al., 1983).  
The “classical” drugs have a similar but more intensive effect on the immune system and 
micro-flora of drug users. The elimination of “good” intestinal bacteria by continually used 
drugs opened the space for amplification of microbes, which had existed before in the 
minority. The result of this process is that the immune system is not able to react to the 
massive attack and many diseases are induced, as: pneumonia, tuberculosis, toxoplasmosis, 
Cryptococcus, hepatitis B, herpes simplex, cytomegalovirus, bacterial, yeast and fungal 
infections, lymph gland infections and immunodeficiency. Amplified pathogenic microbes 
are equipped with antibiotic resistance and some of them are bearing viral and retroviral 
genetic information. Many of these infections are chronic or recurring, often unrecognized at 
first, and difficult to treat. Consequent antibiotic treatment forwards the spiral process of 
natural micro-flora destruction. And finally, ingestion of antiretroviral drugs as AZT 
completed this distortion. The result of such continual, step by step attack of intestinal 
microbes is their unification, reduction of their heterogeneity and loss of their basic function 
for the host. In the intestinal tract of two American AIDS patients in the final phase we 
found only one type of bacteria bearing HIV-1 sequences – multi-resistant Escherichia coli 
with plasmids of about 50 kbp.  
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4. Conclusion  
Hypothetically, bacteria are probably hosts not only for HIV but also for other retroviruses. 
The presence of HIV sequences in commensurate bacteria of the patients may be explained 
as follows: 1) intestinal bacteria were infected by HIV or virus-like particles (VLP) 
previously produced by human cells, in particular by macrophages and lymphocytes; 2) 
intestinal bacteria of AIDS patients are a natural host of HIV sequences in the form of a virus 
or VLP.  
Effective vaccines for human immunodeficiency virus type 1 (HIV-1) will have to stimulate 
protective immunity in the intestinal mucosa, where HIV-1 infection causes severe CD4+ T-
cell depletion (Bealshe et al., 1994; Bartlett et al., 2003). While replication-competent 
recombinant adenovirus (rAd) vectors can stimulate adenovirus-specific mucosal immunity 
after replication, oral delivery of replication-defective rAd vectors encoding specific 
immunogens has proven challenging (Wang et al., 2009).  
Recent studies suggest that induction of primary immune responses by recombinant 
bacterial vectors leads to gut immunization and subsequent systemic boosting elicits potent 
antigen-specific gut mucosal responses. Genetically modified bacteria have been 
experimentally used as recombinant probiotics also in gastrointestinal disorders, but clinical 
usage is currently not the case. Nevertheless, in the future a greater use of this kind of 
approach is expected. The expression of HIV-1 antigens in specific probiotic strains may be 
suitable for clinical use as a potential vaccine. 
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